The Oslo University Hospital (OUS) is a highly specialised hospital in charge of national, regional and local hospital assignments. The hospital is Scandinavia’s largest and yearly carries out more than 1.2 million patient treatments. OUS’ main tasks are patient treatment and care, research, education and training of health personnel. The major part of medical research within the hospital sector in Norway is performed here; with more than 2000 publications and 100-120 PhD graduates annually.
The Department of Cellular Therapy has one of Europe’s biggest and most modern GMP facilities for cellular products. Its Translational Research Unit undertakes complete pre-clinical studies for therapeutic molecules such as vaccines and adoptive T cell transfer (TCR, CAR). The unit can deliver molecular biology products and perform cellular assays and in vivo animal studies with access to key equipment including mass cytometry, IncuCyte, immunomonitoring platforms, and biobanks. The Department of Cellular Therapy participates in the European Cancer Immunotherapy Immunoguiding Program activities.
